La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December ...
GlobeNewswire (press release) Secondary efficacy endpoints include: (i) the change in serum ferritin, the other key measurement used to detect iron overload, from baseline to end of treatment; and (ii) the requirement for and frequency of phlebotomy procedures used during the study ... |
from phlebotomy - Google News http://bit.ly/2ELZ3sz
No comments:
Post a Comment